# Salivary Transcriptome Biomarkers for Early Diabetes Detection

> **NCT02673762** · — · UNKNOWN · sponsor: **PeriRx** · enrollment: 180 (estimated)

## Conditions studied

- Pre-diabetes
- Type II Diabetes
- Insulin Resistance

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02673762
- **Lead sponsor:** PeriRx
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01
- **Primary completion:** 2018-12
- **Final completion:** 2019-02
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2018-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02673762

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02673762, "Salivary Transcriptome Biomarkers for Early Diabetes Detection". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02673762. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*